ERBB2 and breast cancer: Using publicly available TCGA and METABRIC data sets, we demonstrate ECD mRNA is overexpressed in BC and its overexpression predicted shorter survival in ER−, PR−, and TNBC as well as HER2+ BC subtypes (Fig. 5).